A 30-year-old man was admitted to the hospital with a 1-week history of asthenia and febrile angina. Blood tests revealed pancytopenia and 25% immature myeloid cells, but no blast cells. Coagulation tests were normal. Bone marrow aspiration with 93% blasts and numerous clustered Auer rods was highly suggestive of acute promyelocytic leukemia (APL) (panel A: May-Grünwald Giemsa staining, original magnification ×100). Flow cytometry revealed high side scatter with cMPO+, CD33+, CD117+, CD34 (consistent with promyelocytes), but atypical HLA-DR+. PML::RARA fast fluorescence in situ hybridization (FISH) was negative. Cytogenetics revealed loss of chromosome Y and a complex rearrangement involving chromosomes 3 and 7, with a pericentric inversion on chromosome 3 affecting 3p24, which carries the RARB gene (panel B). Due to the lack of RARB-specific FISH probes, further investigation was conducted using optical genome mapping, which identified a chromoplexy involving a 9-partner translocation, resulting in an FNDC3B::RARB fusion (panel C), confirmed by reverse transcription polymerase chain reaction (panel D).

As the patient did not develop a differentiation syndrome with all-trans retinoic acid alone, an induction chemotherapy was added. He achieved complete remission with minimal residual disease below 0.1% by flow cytometry after 2 cycles. However, all-trans retinoic acid’s specific contribution to this outcome remains uncertain. The patient is awaiting allogeneic transplantation. RAR rearrangements beyond RARA occur in ∼2% of APL cases. RARA-negative APLs are typically retinoid-resistant, and their optimal treatment remains undefined. Advanced genetic techniques, such as optical genome mapping or transcriptomics, are crucial to avoid overlooking these variants.

For additional images, visit the ASH Image Bank, a reference and teaching tool that is continually updated with new atlas and case study images. For more information, visit https://imagebank.hematology.org.

Sign in via your Institution